Effects of molecular mass and hydrophobicity on transport rates through non-specific pathways of the silkworm larva midgut

International Journal of Antimicrobial Agents

Volumn 26, Issue 1, 2005, Pages 38-42

  Hamamoto, Hiroshi ^a   Kamura, Koushirou ^a   Razanajatovo, Iony Manitra ^a   Murakami, Kazuhisa ^b   Santa, Tomofumi ^a   Sekimizu, Kazuhisa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

Animal model; Antibiotics; Drug permeability; Silkworm larva; Therapeutic effect

Indexed keywords

CEFCAPENE; CEFCAPENE PIVOXIL; PRODRUG; TETRACYCLINE; VANCOMYCIN;

ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG TRANSPORT; HEMOLYMPH; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; LARVA; MAMMAL; MEMBRANE PERMEABILITY; MIDGUT; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; SILKWORM;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; BOMBYX; CEPHALOSPORINS; GASTROINTESTINAL TRACT; INTESTINAL ABSORPTION; LARVA; MODELS, ANIMAL; MOLECULAR WEIGHT; PRODRUGS; SOLUBILITY;

EID: 20744450295     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.03.008     Document Type: Article

References (21)

1. F.B. Orlans, T.L. Beauchamp, R. Dresser, D.B. Morton, and J.P. Gluck The human use of animals: case studies in ethical choice 1998 Oxford University Press New York/Oxford
2. V. Baumans Use of animals in experimental research: an ethical dilemma? Gene Ther 11 Suppl. 1 2004 S64 S66
3. A. Bernal, and D.A. Kimbrell Drosophila Thor participates in host immune defense and connects a translational regulator with innate immunity Proc Natl Acad Sci USA 97 2000 6019 6024
4. A.J. Needham, M. Kibart, H. Crossley, P.W. Ingham, and S.J. Foster Drosophila melanogaster as a model host for Staphylococcus aureus infection Microbiology 150 2004 2347 2355
5. B.E. Mansfield, M.S. Dionne, D.S. Schneider, and N.E. Freitag Exploration of host-pathogen interactions using Listeria monocytogenes and Drosophila melanogaster Cell Microbiol 5 2003 901 911
6. T. Bae, A.K. Banger, and A. Wallace Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing Proc Natl Acad Sci USA 101 2004 12312 12317
7. H. Hamamoto, K. Kurokawa, and C. Kaito Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms Antimicrob Agents Chemother 48 2004 774 779
8. C. Tagesson, and R. Sjodahl Passage of molecules through the wall of the gastrointestinal tract Intestinal permeability to polyethylene glycols in the 414- to 1,074-dalton range Eur Surg Res 16 1984 274 281
9. J.B. Lloyd Intestinal permeability to polyethyleneglycol and sugars: a re-evaluation Clin Sci (Lond) 95 1998 107 110
10. H. Kubinyui Lipophilicity and drug activity Prog Drug Res 23 1979 97 198
11. Y.L. He, S. Murby, and L. Gifford Oral absorption of d-oligopeptides in rats via the paracellular route Pharm Res 13 1996 1673 1678
12. S. Griffin, S.G. Wyllie, and J. Markham Determination of octanol-water partition coefficient for terpenoids using reversed-phase high-performance liquid chromatography J Chromatogr A 864 1999 221 228
13. M. Konishi, T. Agoh, and R. Nishimura Determination of S-1006 and related compounds in human plasma and urine by high-performance liquid chromatography Chemotherapy 41 1993 154 162
14. N. Akimitsu, H. Hamamoto, and R. Inoue Increase in resistance of methicillin-resistant Staphylococcus aureus to beta-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals Antimicrob Agents Chemother 43 1999 3042 3043
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals, approved standard, M31-A. Wayne, PA: NCCLS; 1999.
16. K. Totsuka, K. Shimizu, M. Konishi, and S. Yamamoto Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans Antimicrob Agents Chemother 36 1992 757 761
17. M. Nakashima, T. Uematsu, and T. Oguma Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores Antimicrob Agents Chemother 36 1992 762 768
18. X. He, M. Sugawara, Y. Takekuma, and K. Miyazaki Absorption of ester prodrugs in Caco-2 and rat intestine models Antimicrob Agents Chemother 48 2004 2604 2609
19. E. Biganzoli, L.A. Cavenaghi, R. Rossi, M.C. Brunati, and M.L. Nolli Use of a Caco-2 cell culture model for the characterization of intestinal absorption of antibiotics Farmaco 54 1999 594 599
20. R. Saitoh, K. Sugano, and N. Takata Correction of permeability with pore radius of tight junctions in Caco-2 monolayers improves the prediction of the dose fraction of hydrophilic drugs absorbed by humans Pharm Res 21 2004 749 755
21. M. Wafik Gouda Effect of an antidiarrhoeal mixture on the bioavailability of tetracycline Int J Pharm 89 1993 75 77